CD4+ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy.
CD4+ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy. Sci Immunol. 2024 09 13; 9(99):eadp6529.